CXCL12 and cancer: Notably, CXCR4 antagonists can be used as potential drug sensitizers since treatment-induced CXCL12 pathway activation might be involved in acquired drug-resistance mechanisms through several processes, including induction of cancer cell survival, invasion, and stem cell phenotype [33].